Novo Nordisk presented the phase 3 monotherapy results in September 2025 and submitted an NDA for CagriSema to the FDA on 18 December 2025, based on REDEFINE 1 and REDEFINE 2
Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis
BPC-157 and Sperm Quality Improvements BPC-157 demonstrates significant benefits for sperm quality through its effects on vascular health and tissue repair
Zhao Q, Zhou L, Liu J, Cao Z, Du X, Huang F, et al
He came under additional fire for insisting that Bulletproof coffee is processed to eliminate mycotoxins (toxic mold), and got a huge bump in sales when he touted this on the Joe Rogan podcast in 2014
No one should stop or change a prescription on their own, especially for diabetes